Gram L F
Psychopharmacol Commun. 1975;1(2):165-75.
In previous studies we have shown that perphenazine inhibits the metabolism of nortriptyline and imipramine. In this study the metabolism of 14C-imipramine and 14C-desipramine was studied before and during treatment with perphenazine. Studies on the imipramine and desipramine metabolites in urine showed that the major effect of perphenazine is an inhibition of the 2-hydroxylation of imipramine and desipramine. This causes a decreased formation and excretion of non-conjugated and glucuronide bound hydroxy metabolites and accumulation of imipramine and desipramine. There was some relationship between the dose of perphenazine and the decrease in total urinary excretion but the individual variations in response were pronounced (2-3-fold).
在之前的研究中,我们已经表明奋乃静会抑制去甲替林和丙咪嗪的代谢。在本研究中,我们研究了在使用奋乃静治疗前和治疗期间14C-丙咪嗪和14C-去甲丙咪嗪的代谢情况。对尿液中丙咪嗪和去甲丙咪嗪代谢物的研究表明,奋乃静的主要作用是抑制丙咪嗪和去甲丙咪嗪的2-羟基化。这导致未结合和葡糖醛酸结合的羟基代谢物的形成和排泄减少,以及丙咪嗪和去甲丙咪嗪的蓄积。奋乃静剂量与尿总排泄量减少之间存在一定关系,但个体反应差异显著(2至3倍)。